PYRAZOLYLBENZENE-1,3-DIOLS FOR DISEASES ASSOCIATED WITH G PROTEIN-COUPLED RECEPTOR 18 AND IN COMBINATION WITH TRANSIENT RECEPTOR POTENTIAL VANILLOID 1
申请人:Temple University-Of The Commonwealth System of Higher Education
公开号:US20210323927A1
公开(公告)日:2021-10-21
The present invention relates to pyrazolylbenzene-1,3-diols as cannabidiol derivatives, its use for the manufacture of a medicament, and more particularly, to the use of this medicament for the treatment and/or prevention of a disorder associated with the GPR18 and/or TRPV1 receptors and the use of these compounds for pharmacological assays related to GPR18 and/or TRPV1.
本发明涉及吡唑基苯-1,3-二酚作为大麻二酚衍生物,其用于制造药物,并更具体地,用于治疗和/或预防与GPR18和/或TRPV1受体相关的疾病的药物的使用,以及利用这些化合物进行与GPR18和/或TRPV1相关的药理学测定的用途。